<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-7026</journal-id>
<journal-title><![CDATA[Psicología, Conocimiento y Sociedad]]></journal-title>
<abbrev-journal-title><![CDATA[Psicol. Conoc. Soc.]]></abbrev-journal-title>
<issn>1688-7026</issn>
<publisher>
<publisher-name><![CDATA[Facultad de Psicología. Universidad de la República]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-70262018000200176</article-id>
<article-id pub-id-type="doi">10.26864/pcs.v8.n2.12</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Paradigmas psiquiátricos y psicofarmacología. ¿Relevancia del órgano-dinamismo de Henry Ey?]]></article-title>
<article-title xml:lang="en"><![CDATA[Psychiatric paradigms and psychopharmacology]]></article-title>
<article-title xml:lang="pt"><![CDATA[Paradigmas psiquiátricos e psicofarmacologia. ¿Relevância da organo-dinâmica de Henry Ey?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Toledo]]></surname>
<given-names><![CDATA[Mauricio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Almada]]></surname>
<given-names><![CDATA[Ramiro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Villalba]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Vilardebó Unidad Farmacología Clínica ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Vilardebó  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Asociación Psicoanalítica del Uruguay  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>8</volume>
<numero>2</numero>
<fpage>176</fpage>
<lpage>191</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-70262018000200176&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-70262018000200176&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-70262018000200176&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La psicofarmacología se ha constituido a lo largo de las últimas décadas en una herramienta fundamental para el abordaje del tratamiento de los trastornos psiquiátricos. Como todos los desarrollos tecnológicos eficaces y capaces de generar cambios sustantivos tiene luces y sombras. El desarrollo de los antipsicóticos, antidepresivos y ansiolíticos permitió comenzar a tratar eficazmente los procesos mórbidos psiquiátricos como nunca antes se había realizado. A tal punto, que socavó el concepto de asilo psiquiátrico por el de hospital o unidades de atención, es decir, se generó una nueva organización asistencial. Sin embargo, aún estamos lejos de una opción fármaco-terapéutica óptima. En un contexto asistencial donde se observa un incremento del consumo de psicofármacos, el desarrollo por parte de la industria farmacéutica de moléculas que no constituyen novedades terapéuticas y un sistema de investigación tutelado por la mirada de la medicina basada en las evidencias. A su vez, la psiquiatría actual está inmersa en un pluralismo teórico y epistemológico que ha desterrado a la psicopatología como forma de entender o interpretar el síntoma. Esta doble condición de pluralismo teórico y un uso a veces inadecuado de la fármaco-terapia condicionan nuestra práctica clínica. En el presente trabajo tenemos como objetivo abordar genéricamente el desarrollo de la psiquiatría desde la perspectiva de los paradigmas, la génesis y el desarrollo psicofarmacológico y considerar la relevancia de un modelo psicopatológico como el organodinamismo de Henry Ey.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Psychopharmacology has been constituted over the last decades in a fundamental tool for addressing the treatment of psychiatric disorders. Like all technological developments that are effective and capable of generating substantive changes, there are lights and shadows. The development of antipsychotics, antidepressants and anxiolytics allowed to begin to effectively treat morbid psychiatric processes as never before. To such an extent, that it undermined the concept of psychiatric asylum by that of hospital or care units, that is, a new healthcare organization was created. However, we are still far from an optimal pharmaco-therapeutic option. In an assistance context where there is an increase in the consumption of psychotropic drugs, the development by the pharmaceutical industry of molecules that do not constitute therapeutic novelties and a research system guided by the eyes of medicine based on evidence. In turn, current psychiatry is immersed in a theoretical and epistemological pluralism that has banished psychopathology as a way of understanding or interpreting the symptom. This double condition of theoretical pluralism and sometimes inadequate use of the drug-therapy condition our clinical practice. In this work we aim to address generically the development of psychiatry from the perspective of paradigms, genesis and psychopharmacological development and consider the relevance of a psychopathological model such as Henry Ey's organo-dynamism.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: A psicofarmacologia tem se constituído nas últimas décadas em uma ferramenta fundamental para abordar o tratamento de transtornos psiquiátricos. Como todos os desenvolvimentos tecnológicos que são eficazes e capazes de gerar mudanças substantivas, há luzes e sombras. O desenvolvimento de antipsicóticos, antidepressivos e ansiolíticos permitiu começar a tratar eficazmente os processos psiquiátricos mórbidos como nunca antes. De tal forma, que minou o conceito de asilo psiquiátrico por meio de unidades hospitalares ou de atendimento, ou seja, uma nova organização de saúde foi criada. No entanto, ainda estamos longe de ser uma ótima opção farmacoterapêutica. Em um contexto de assistência onde há um aumento no consumo de psicofármacos, o desenvolvimento pela indústria farmacêutica de moléculas que não constituem novidades terapêuticas e um sistema de pesquisa guiado pelos olhos da medicina baseada em evidências. Por sua vez, a psiquiatria atual está imersa em um pluralismo teórico e epistemológico que baniu a psicopatologia como uma maneira de entender ou interpretar o sintoma. Essa dupla condição de pluralismo teórico e, às vezes, uso inadequado da farmacoterapia condiciona nossa prática clínica. Neste trabalho pretendemos abordar genericamente o desenvolvimento da psiquiatria na perspectiva de paradigmas, gênese e desenvolvimento psicofarmacológico e considerar a relevância de um modelo psicopatológico como o organodinamismo de Henry Ey.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Psiquiatría]]></kwd>
<kwd lng="es"><![CDATA[Paradigmas]]></kwd>
<kwd lng="es"><![CDATA[Psicofarmacología]]></kwd>
<kwd lng="es"><![CDATA[Órgano-dinamismo]]></kwd>
<kwd lng="en"><![CDATA[Psychiatry]]></kwd>
<kwd lng="en"><![CDATA[Paradigms]]></kwd>
<kwd lng="en"><![CDATA[Psychopharmacology]]></kwd>
<kwd lng="en"><![CDATA[Organo-dynamism]]></kwd>
<kwd lng="pt"><![CDATA[Psiquiatria]]></kwd>
<kwd lng="pt"><![CDATA[Paradigmas]]></kwd>
<kwd lng="pt"><![CDATA[Psicofarmacologia]]></kwd>
<kwd lng="pt"><![CDATA[Organo-dinâmica]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[Utilización de antipsicóticos en España (1992-2006)]]></source>
<year>2007</year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[Informe de utilización de medicamentos. Utilización de medicamentos antidepresivos en España durante el periodo 2000-2013]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andreasen]]></surname>
<given-names><![CDATA[N. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[DSM and the Death of Phenomenology in America: An Example of Unintended Consequences]]></article-title>
<source><![CDATA[Schizophrenia Bulletin]]></source>
<year>2007</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>108-12</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="book">
<collab>Asociación de Psiquiatría Americana</collab>
<source><![CDATA[Manual diagnóstico y estadístico de los trastornos mentales, DSM-IV-TR]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Masson]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baños]]></surname>
<given-names><![CDATA[J. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Farré]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Principios de Farmacología Clínica: bases científicas de la utilización de medicamentos]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Masson]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barcia Salorio]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Historia de la Psiquiatría]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Ruiloba]]></surname>
<given-names><![CDATA[J. Vallejo]]></given-names>
</name>
<name>
<surname><![CDATA[Cercós]]></surname>
<given-names><![CDATA[C. Leal]]></given-names>
</name>
</person-group>
<source><![CDATA[Tratado de Psiquiatría]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Marbán]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berrios]]></surname>
<given-names><![CDATA[G. E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Historia de los síntomas de los trastornos mentales]]></source>
<year>2008</year>
<publisher-loc><![CDATA[México, D.F. ]]></publisher-loc>
<publisher-name><![CDATA[Fondo de Cultura Económica]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berrios]]></surname>
<given-names><![CDATA[G. E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Hacia una nueva epistemología de la psiquiatría]]></source>
<year>2011</year>
<edition>1ed</edition>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Polemos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bertolote]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Raíces del concepto de salud mental]]></article-title>
<source><![CDATA[World Psychiatry]]></source>
<year>2008</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boorse]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[On the distinction between disease and illness]]></article-title>
<source><![CDATA[Philosophy and Public Affairs]]></source>
<year>1975</year>
<volume>5</volume>
<page-range>49-68</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correll]]></surname>
<given-names><![CDATA[C. U.]]></given-names>
</name>
<name>
<surname><![CDATA[Gallego]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice]]></article-title>
<source><![CDATA[Psychiatr Clin N Am.]]></source>
<year>2012</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>661-81</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuthbert]]></surname>
<given-names><![CDATA[B. N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Translating intermediate phenotypes to psychopathology: the NIMH Research Domain Criteria]]></article-title>
<source><![CDATA[Psychophysiology]]></source>
<year>2014</year>
<volume>51</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1205-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<collab>Evidence-Based Medicine Working Group. Evidence-based medicine</collab>
<article-title xml:lang=""><![CDATA[A new approach to teaching the practice of medicine]]></article-title>
<source><![CDATA[Jama]]></source>
<year>1992</year>
<volume>268</volume>
<numero>17</numero>
<issue>17</issue>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ey]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio No 4, La posición de la psiquiatría dentro del marco de las ciencias médicas (la noción de &#8220;enfermedad mental&#8221;)]]></article-title>
<source><![CDATA[Estudios Psiquiátricos]]></source>
<year>2008</year>
<page-range>67-82</page-range><publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Polemos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ey]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Bernard]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Brisset]]></surname>
<given-names><![CDATA[C.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Capítulo 1. Parte III: Organización de la vida psíquica]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Ey]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Bernard]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Brisset]]></surname>
<given-names><![CDATA[C.H.]]></given-names>
</name>
</person-group>
<source><![CDATA[Tratado de Psiquiatría]]></source>
<year>1978</year>
<edition>8ª ed de la 5ª ed francesa</edition>
<page-range>28-34</page-range><publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Masson]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallego]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Bonetti]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kane]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Correll]]></surname>
<given-names><![CDATA[C. U.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009]]></article-title>
<source><![CDATA[Schizophr Res]]></source>
<year>2012</year>
<volume>138</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>18-28</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghaemi]]></surname>
<given-names><![CDATA[S. N.]]></given-names>
</name>
</person-group>
<source><![CDATA[Estadística y Epidemiología en Salud Mental. Guía clínica]]></source>
<year>2015</year>
<edition>1a ed.</edition>
<publisher-loc><![CDATA[Santiago ]]></publisher-loc>
<publisher-name><![CDATA[Mediterráneo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hálfdánarson]]></surname>
<given-names><![CDATA[Ó.]]></given-names>
</name>
<name>
<surname><![CDATA[Zoëga]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Aagaard]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Bernardo]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Fusté]]></surname>
<given-names><![CDATA[A.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Furu]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Bachmann]]></surname>
<given-names><![CDATA[C.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International trends in antipsychotics use: a study in 16 countries, 2005-2014]]></article-title>
<source><![CDATA[EurNeuropsychopharmacol]]></source>
<year>2017</year>
<volume>27</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1064-76</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Healy]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[The Creation of Psychopharmacology]]></source>
<year>2002</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Harvard University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Healy]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatric Drugs Explained]]></source>
<year>2016</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ilyas]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Moncrieff]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010]]></article-title>
<source><![CDATA[The British Journal of Psychiatry]]></source>
<year>2012</year>
<volume>200</volume>
<page-range>393-8</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kendler]]></surname>
<given-names><![CDATA[K. S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The nature of psychiatric disorders]]></article-title>
<source><![CDATA[World Psychiatry]]></source>
<year>2016</year>
<volume>15</volume>
<page-range>5-12</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kingma]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Naturalist accounts of mental disorder, The Oxford Handbook of philosophy and psychiatry]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Oxford ]]></publisher-loc>
<publisher-name><![CDATA[Oxford University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klerman]]></surname>
<given-names><![CDATA[G. L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychotropic Hedonism vs. Pharmacological Calvinism]]></article-title>
<source><![CDATA[The Hastings Center Report]]></source>
<year>1972</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1-3</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lanteri Laura]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Ensayo sobre los paradigmas de la psiquiatría moderna]]></source>
<year>2000</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Tricastela]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levin]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Apuntes para un análisis epistemológico de algunos problemas de la psiquiatría contemporánea]]></article-title>
<source><![CDATA[Vertex]]></source>
<year>2010</year>
<volume>21</volume>
<numero>91</numero>
<issue>91</issue>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mars]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kessler]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[N.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[R.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[K.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Gunnell]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influences on antidepressant prescribing trends in the UK: 1995-2011]]></article-title>
<source><![CDATA[Social Psychiatry and Psychiatric Epidemiology]]></source>
<year>2017</year>
<volume>52</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>193-200</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mc Hugh]]></surname>
<given-names><![CDATA[P. R]]></given-names>
</name>
<name>
<surname><![CDATA[Slavney]]></surname>
<given-names><![CDATA[P. R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Perspectivas de la Psiquiatría]]></source>
<year>1985</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Masson]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Möller]]></surname>
<given-names><![CDATA[H. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness studies: advantages and disadvantages]]></article-title>
<source><![CDATA[Dialogues Clin Neurosci]]></source>
<year>2011</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>199-207</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morkem]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Barber]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Williamson]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Patten]]></surname>
<given-names><![CDATA[S. B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Canadian Primary Care Sentinel Surveillance Network Study Evaluating Antidepressant Prescribing in Canada From 2006 to 2012]]></article-title>
<source><![CDATA[CanJPsychiatry]]></source>
<year>2012</year>
<volume>60</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>564-70</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mundt]]></surname>
<given-names><![CDATA[A. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Aichberger]]></surname>
<given-names><![CDATA[M. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Fakhriddinov]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Fayzirahmanova]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Grohmann]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Heinz]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ströhle]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescription patterns of patients diagnosed with schizophrenia in mental hospitals in Tashkent/Uzbekistan and in four German cities]]></article-title>
<source><![CDATA[Pharmacoepidemiol Drug Saf]]></source>
<year>2012</year>
<volume>21</volume>
<page-range>145-51</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<collab>Organización Mundial de la Salud</collab>
<article-title xml:lang=""><![CDATA[Promoción del uso racional de medicamentos: componentes centrales]]></article-title>
<source><![CDATA[Perspectivas políticas sobre medicamentos de la OMS]]></source>
<year>2002</year>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patsopoulos]]></surname>
<given-names><![CDATA[N. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A pragmatic view on pragmatic trials]]></article-title>
<source><![CDATA[Dialogues Clin Neurosci]]></source>
<year>2011</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>217-24</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pringsheim]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Gardner]]></surname>
<given-names><![CDATA[D. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study]]></article-title>
<source><![CDATA[CMAJ Open]]></source>
<year>2014</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>225-32</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stagnaro]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Elementos para pensar una psiquiatría dinámica hoy]]></article-title>
<source><![CDATA[Psicoanálisis APdeBA]]></source>
<year>2006</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>171-87</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Imbriago]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Sarries]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilización de antidepresivos en pacientes ambulatorios del Hospital Policial]]></article-title>
<source><![CDATA[Rev Psiquiatr Urug]]></source>
<year>2015</year>
<volume>79</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>39-48</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[E. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Matthews]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Linardatos]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Tell]]></surname>
<given-names><![CDATA[R. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenthal]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Selective publication of antidepressant trials and its influence on apparent efficacy]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2008</year>
<volume>358</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>252-60</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo Ruiloba]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Leal Cercós]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Tratado de Psiquiatría. Historia de la psiquiatría]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Marbán]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wakefield]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Disorder as harmful dysfunction: a conceptual critique of DSM-III-R&#8217;s definition of mental disorder]]></article-title>
<source><![CDATA[Psychological Review]]></source>
<year>1992</year>
<volume>99</volume>
<page-range>232-47</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
